Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology
of plant molecular farming, and remain some of the brightest prospects for the success of this …

In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …

Plants have been identified as promising expression systems for commercial production of
vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been …

Plants provide not only food and feed, but also herbal medicines and various raw materials
for industry. Moreover, plants can be green factories producing high value bioproducts such …

Plant molecular farming offers a cost‐effective and scalable approach to the expression of
recombinant proteins which has been proposed as an alternative to conventional production …

Aquaculture has undergone rapid development in the past decades. It provides a large part
of high-quality protein food for humans, and thus, a sustainable aquaculture industry is of …

Rabies is an acute, fatal, neurological disease that affects almost all kinds of mammals.
Vaccination (using an inactivated rabies vaccine), combined with administration of rabies …

During the past two decades, antibodies, antibody derivatives and vaccines have been
developed for therapeutic and diagnostic applications in human and veterinary medicine …

Rabies, the most fatal of all infectious diseases, remains a major public health problem in
developing countries, claiming the lives of an estimated 55,000 people each year. Most fatal …

The introduction of exogenous genes into plants permits the development of a new
generation of biological products, ie, edible vaccines. Cereals, especially maize, have been …